Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors: Evaluation in the Real-world Setting

NCT07180693 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07180693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors: Evaluation in the Real-world Setting
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
September 29, 2025
Completion date
August 1, 2030
Enrollment
750 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant therapy, cdk4/6 inhibitor